GeneDx Integrates with Epic to Expand Genome and Exome Sequencing for Faster Diagnosis and Treatment GeneDx (Nasdaq: WGS), a leader in genomic insights for improved health outcomes, announced the launch of its integration with Aura, Epic’s specialty diagnostics suite. This…
Incyte Reports Q4 and Year-End 2024 Results, Provides 2025 Financial Outlook and R&D Milestones Incyte (Nasdaq: INCY) has announced its financial results for the fourth quarter and full year ended December 31, 2024, along with its financial guidance for 2025.…
Synedgen Appoints Dr. Laura Saward as Chief Scientific Officer Synedgen, Inc., a biotechnology company focused on glycobiology to treat gastrointestinal diseases, has appointed Dr. Laura Saward, PhD, as its Chief Scientific Officer. Dr. Saward brings over 25 years of experience…
Cotiviti to Acquire Edifecs in Strategic Deal Cotiviti, a leader in data-driven healthcare solutions, has announced an agreement to acquire Edifecs, a trailblazer in healthcare data interoperability. This strategic acquisition aims to create a combined platform that will strengthen connectivity…
Aurion Biotech Names Donald Munoz as New Chief Financial Officer Aurion Biotech, Inc. (Aurion), a company dedicated to restoring vision for millions through transformative regenerative therapies, announced today the appointment of Donald Munoz as its new Chief Financial Officer (CFO).…
Cancer Center Welcomes RefleXion’s SCINTIX Therapy with First Installation at BHCC RefleXion Medical, a leader in theranostic oncology, has announced that its RefleXion® X1 platform, featuring SCINTIX® biology-guided radiotherapy, will be installed at Beverly Hills Cancer Center (BHCC). This marks…
AdvanCell Partners with Lilly to Develop Targeted Alpha Therapies for Cancer AdvanCell, a clinical-stage radiopharmaceutical company focused on targeted alpha therapies, today revealed an expansion of its strategic collaboration with Eli Lilly and Company. This expanded partnership aims to research…
NCCN Enhances ctDNA Guidance for Colon, Rectal, and Merkel Cell Cancers Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, has recently commented on the updated guidelines by the National Comprehensive Cancer Network (NCCN) regarding circulating…
Invisalign® Palatal Expander Now Available in Turkey for Growing Patients Align Technology, Inc. (Nasdaq: ALGN), a global leader in medical devices, specializing in the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and…
Healthcare Services Expansion: DocGo Acquires PTI Health to Enhance Mobile Offerings DocGo Inc. (Nasdaq: DCGO), a leader in technology-driven mobile health services, has announced the acquisition of PTI Health, a mobile lab collection and phlebotomy services provider based in the…
Satellos Completes Enrollment for Phase 1 SAT-3247 Trial in Healthy Volunteers Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotech company focused on developing small molecule therapies to treat muscle diseases, has announced the completion of enrollment for all four…
Ibex Medical Analytics Secures First FDA 510(k) Clearance Ibex Medical Analytics, a leader in AI-powered cancer diagnostics, has announced that it has received FDA 510(k) clearance for its innovative product, Ibex Prostate Detect. This in vitro diagnostic medical device leverages…